Resveratrol lowers breast cancer risk by blocking estrogen growth factor
(NaturalNews) Researchers from the Faculty of Pharmacy at the University of Calabria in Italy publishing in The FASEB Journal report that resveratrol blocks the effect of estrogen and can help to prevent the malignant growth of breast cancer in women. The grape/red wine derivative has been the subject of numerous scientific studies in recent years and has shown promise in lowering risks from cardiovascular disease, cancer and dementia. Scientists also believe the protective nutrient may extend healthy lifespan by directly influencing mortality genes known as SIRT. Health-minded adults will want to include resveratrol from natural food sources or supplementation to reap the numerous health benefits.
To design their study, researchers used several breast cancer cell lines expressing the estrogen receptor to test the effects of resveratrol. They exposed the different cells to a solution containing resveratrol and compared the results to cells left untreated. They found an important reduction in cell growth in cells treated with resveratrol, while no changes were seen in untreated cells. Further experiments determined that this effect was caused by a critical reduction in estrogen receptors caused by the administration of resveratrol.